Search Results - Pedro Herranz

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol

    European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in pat... by Matthias Augustin, Hilde Lapeere, Anthony Bewley, Christian Vestergaard, Thomas Werfel, Eric Massana, Ismail Kasujee, Marie-Charlotte Brüggen, Marjolein S de Bruin-Weller, Khaled Ezzedine, Silvia M Ferrucci, Spyridon Gkalpakiotis, Pedro Herranz, Emma K Johansson, Tomáš Kampe, Franz J Legat, Eva Maria Rehbinder, Jacek C Szepietowski, Tiago Torres, Arnau Domenech, Volker Koscielny, Siva Narayanan, Jan Gutermuth

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Patient Burden And Impact Of Moderate-to-Severe Atopic Dermatitis In the Spanish Healthcare System: The APOLO Cross-Sectional Study

    Patient Burden And Impact Of Moderate-to-Severe Atopic Dermatitis In the Spanish Healthcare System: The APOLO Cross-Sectional Study by Pablo De La Cueva Dobao, Laia Curto Barredo, Juan Francisco Silvestre Salvador, Esther Serra Baldrich, Pedro Herranz Pinto, Natalia Hernández Cano, Francisco Javier Ortiz De Frutos, Gastón Roustan Gullón, Rosa María Izu Belloso, Irene Arévalo Ortega, Alicia González Quesada, Manuel Galán Gutiérrez, Yolanda Gilaberte Calzada, Daniel Arumi Torredemer, Noelia Llevat Felius, Irene Hernández Martín, Francisco José Rebollo Laserna

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: